摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(4-benzyl-piperidine-1-yl)-(1-phenyl-3-thiophen-2-yl-1H-pyrazol-4-yl)-methanone | 6551-86-6

中文名称
——
中文别名
——
英文名称
(4-benzyl-piperidine-1-yl)-(1-phenyl-3-thiophen-2-yl-1H-pyrazol-4-yl)-methanone
英文别名
(4-Benzylpiperidin-1-yl)-(1-phenyl-3-thiophen-2-ylpyrazol-4-yl)methanone
(4-benzyl-piperidine-1-yl)-(1-phenyl-3-thiophen-2-yl-1H-pyrazol-4-yl)-methanone化学式
CAS
6551-86-6
化学式
C26H25N3OS
mdl
——
分子量
427.57
InChiKey
YQAMECSUDVXDTN-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5.4
  • 重原子数:
    31
  • 可旋转键数:
    5
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.23
  • 拓扑面积:
    66.4
  • 氢给体数:
    0
  • 氢受体数:
    3

文献信息

  • [EN] MODULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTORS ACTIVITY<br/>[FR] MODULATION DE L'ACTIVITE DES RECEPTEURS ACTIVES PAR LES PROLIFERATEURS DE PEROXYSOMES
    申请人:CAREX SA
    公开号:WO2004037248A2
    公开(公告)日:2004-05-06
    The present invention relates to compounds, compositions and methods useful for modulating nuclear receptors activity in cells, and for treating and/or preventing various diseases and conditions mediated by said nuclear receptors, including metabolic or cell proliferative disorders. According to particular aspects, the present invention relates to compounds, compositions and methods useful for modulating activities of the Peroxisome Proliferator Activated Receptors (PPARs) and for treating and/or preventing various diseases and conditions mediated by said nuclear receptors. More specifically, it relates to Peroxisome Proliferator Activated Receptor-gamma (PPAR-gamma) ligands, which are useful in the modulation of blood glucose levels and in the increase of insulin sensitivity in patients in need thereof. The properties of the compounds and compositions of the invention make these PPAR ligands particularly useful in the treatment of those diseases and conditions including diabetes, atherosclerosis, hyperglycemia, dyslipidemia, obesity, syndrome X, insulin resistance, hypertension, neuropathy, microvascular diseases (e.g. retinopathy, nephropathy), macrovascular diseases (e.g. myocardial infarction, stroke, heart failure) in mammals.
查看更多